Literature DB >> 15115876

Objective assessment of criteria for selection of donor lungs suitable for transplantation.

A J Fisher1, S C Donnelly, G Pritchard, J H Dark, P A Corris.   

Abstract

BACKGROUND: Donor organ shortage severely limits lung transplantation as a therapeutic option, yet many potential donor lungs are deemed unsuitable by clinical selection criteria.
METHODS: Of 39 consecutive potential donor lungs, 14 were accepted and 25 excluded by clinical selection criteria. All were evaluated prospectively by clinical assessment, bronchoscopy, and bronchoalveolar lavage (BAL) to evaluate objectively the discrimination of pulmonary infection and injury.
RESULTS: Accepted donors were significantly younger than those excluded (mean (SD) age 36.7 (15.3) years v 49.5 (13.2) years; p = 0.009, unpaired t test) and were more likely to have suffered traumatic brain death (50% v 20%; p = 0.07, Fisher's exact test). Oxygenation (PaO(2):FiO(2)) was higher in accepted donors than in excluded donors (median (range) 63.2 (48-82.5) kPa v 43.1 (7.7-71.7) kPa; p = 0.0001, Mann-Whitney test). Positive formal BAL culture was more frequent in accepted donors (75%) than in those excluded (43%; p = 0.1, Fisher's exact test). There was no significant difference in the percentage and concentration of neutrophils in BAL fluid between accepted and excluded donors (median (range) 37.9 (0-96.9)% and 44.6 (0-1190)x10(3)/ml v 36 (1-98.1)% and 46 (0.2-1457)x10(3)/ml), nor in the BAL fluid concentration of tumour necrosis factor-alpha (140 (0-340) pg/ml v 160 (0-760) pg/ml) or interleukin 8 (810 (33-17 600) pg/ml v 540 (0-15 110) pg/ml).
CONCLUSION: Current selection criteria are poor discriminators of pulmonary injury and infection and lead to the exclusion of potentially usable donor lungs.

Entities:  

Mesh:

Year:  2004        PMID: 15115876      PMCID: PMC1747005          DOI: 10.1136/thx.2003.007542

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury.

Authors:  A J Fisher; S C Donnelly; N Hirani; M D Burdick; R M Strieter; J H Dark; P A Corris
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Marginal donor lungs: a reassessment.

Authors:  Andrew F Pierre; Yasuo Sekine; Michael A Hutcheon; Thomas K Waddell; Shaf H Keshavjee
Journal:  J Thorac Cardiovasc Surg       Date:  2002-03       Impact factor: 5.209

3.  Pulmonary vein gas analysis for assessing donor lung function.

Authors:  Tarek M Aziz; Ahmed El-Gamel; Rasheed A G Saad; Marcello Migliore; Colin S Campbell; Nizar A Yonan
Journal:  Ann Thorac Surg       Date:  2002-05       Impact factor: 4.330

Review 4.  Lung transplantation: donor selection.

Authors:  T L Winton
Journal:  Semin Thorac Cardiovasc Surg       Date:  1992-04

5.  Assessment of lungs rejected for transplantation and implications for donor selection.

Authors:  Lorraine B Ware; Yibing Wang; Xiaohui Fang; Martha Warnock; Tsutomu Sakuma; Timothy S Hall; Michael Matthay
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

6.  Comparison of outcomes between living donor and cadaveric lung transplantation in children.

Authors:  V A Starnes; M S Woo; E F MacLaughlin; M V Horn; P C Wong; J M Rowland; C L Durst; W J Wells; M L Barr
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

7.  Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.

Authors:  A J Fisher; S C Donnelly; N Hirani; C Haslett; R M Strieter; J H Dark; P A Corris
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

8.  A positive donor gram stain does not predict outcome following lung transplantation.

Authors:  David Weill; Gerald C Dey; R Alan Hicks; K Randall Young; George L Zorn; James K Kirklin; Lesley Early; David C McGiffin
Journal:  J Heart Lung Transplant       Date:  2002-05       Impact factor: 10.247

9.  Intrathoracic organ transplantation in the United Kingdom 1995-99: results from the UK cardiothoracic transplant audit.

Authors:  A C Anyanwu; C A Rogers; A J Murday
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

10.  Donor criteria in lung transplantation: an issue revisited.

Authors:  David Weill
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

View more
  5 in total

1.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

2.  Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Danai M Karamanou; Colin S Gillespie; Faruk Özalp; Tanveer Butt; Paul Hill; Kasim Jiwa; Hannah R Walden; Nicola J Green; Lee A Borthwick; Stephen C Clark; Henning Pauli; Kate F Gould; Paul A Corris; Simi Ali; John H Dark; Andrew J Fisher
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

3.  Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

Authors:  D F McAuley; G F Curley; U I Hamid; J G Laffey; J Abbott; D H McKenna; X Fang; M A Matthay; J W Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-14       Impact factor: 5.464

4.  Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs.

Authors:  John Robert Ferdinand; Morvern Isabel Morrison; Anders Andreasson; Catriona Charlton; Alisha Kaur Chhatwal; William Earl Scott; Lee Anthony Borthwick; Menna Ruth Clatworthy; Andrew J Fisher
Journal:  Clin Transplant       Date:  2022-01-10       Impact factor: 3.456

5.  How I manage the adult potential organ donor: donation after neurological death (part 1).

Authors:  Jennifer A Frontera; Thomas Kalb
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.